Check out your Company Bowl for anonymous work chats.
Our Blueprint for Athletes biometric testing service has a new app that allows fitness enthusiasts to view test results on the go, in an easy-to-read dashboard format that integrates seamlessly into Apple Health Kit. Find out more.
“Science is all around us. I strongly believe having exposure to careers in science at an early age helps students to see themselves in those roles in the future,” said Dr. Steven Sykes, Scientific Director, Quest Diagnostics.
"In 2018 our guidance for the full year is aligned with our long term outlook even before the meaningful benefit of tax reform," said Steve Rusckowski, Chairman, CEO and President. "We expect to deliver continued acceleration of top-line growth of 4-5% and more than 20% adjusted earnings growth, driven in part by solid mid to high single digit earnings growth from operations."
We are honored to be included among the World's Most Admired Companies for the third consecutive year by Fortune Magazine.
Watch our CEO Steve Rusckowski discussing corporate strategy, tax reform, and more with Fox Business Network's Maria Bartiromo at the 36th annual JP Morgan Healthcare Conference.
Our CEO, Steve Rusckowski, meets with senior leaders on Jan. 8, 2018, at our San Juan Capistrano facility to discuss results and strategy ahead of attending the 36th annual JP Morgan Healthcare Conference this week in San Francisco.
Quest Diagnostics is proud to be part of the Foundation’s recently formed Gold Corporate Council, whose five founding members also include BD, Henry Schein, IBM Watson Health, and Medtronic.
On Oct 21, Quest Diagnostics employees joined more than 100 community volunteers at the National AIDS Memorial in San Francisco to announce a $100,000 grant to bolster the memorial’s volunteer workday program in 2018. We're proud to help maintain the 10-acre landmark as a beautiful space for healing and remembrance for those who have been impacted by the AIDS epidemic.
Cleveland HeartLab is to be the base for Quest's first national center of excellence in cardiometabolic disorders, with a focus on services that help patients and physicians nationwide identify hidden risks of heart disease.
"This transaction builds on the strong relationship we've built with Hartford HealthCare, as well as providers and patients across the region who benefit from greater access to Quest's diagnostic insights and innovations," said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics. "It is also the fifth strategically aligned, accretive acquisition we've announced in 2017, delivering on our two-point strategy to accelerate growth and drive operational excellence, while strengthening our presence in New England."
